Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial (Q24685494)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial |
scientific article |
Statements
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial (English)
0 references
Bifidobacterium longum
1 reference
February 2005
0 references
54
0 references
2
0 references
242-9
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference